Navigation Links
CNIO researchers 'capture' the replication of the human genome for the first time
Date:4/25/2013

The Genomic Instability Group led by researcher scar Fernndez-Capetillo at the Spanish National Cancer Research Centre (CNIO), has for the first time obtained a panoramic photo of the proteins that take part in human DNA division, a process known as replication.

The research article, published today in the journal Cell Reports, is the result of a collaborative study in which other CNIO groups have also participated, including the Proteomics Unit led by Javier Muoz and the DNA Replication Group led by Juan Mndez.

DNA replication is the chemical process that sustains cell division, and thus one of the biological mechanisms targeted by most chemotherapeutic agents in order to destroy tumour cells.

To date, multiple independent molecular studies carried out over the last decades have given a general idea of the proteins involved in the replication process. "We suspected that there might be several dozen proteins that control this process meticulously, thus ensuring the correct duplication of our genome as an indispensible step prior to cell division," explains Fernndez-Capetillo.

Thanks to the development of a new technology that allows to isolate recently synthesised DNA, in addition to sophisticated proteomic detection tools (the iPOND-MS technique), CNIO researchers have for the first time been able to precisely draw out, in a single experiment, the replication machinery. These results represent the first proteomic characterisation of the replisome.

According to the authors, the proteins identified have very different activities: they open up the DNA double helix, copy it, repair any breaks if needs be, modify it in different ways, etc. "In short, they're all necessary in order to ensure the correct duplication of the DNA and avoid aberrations in the genetic material that form the basis of tumours", states Fernndez-Capetillo.

NEW REPLICATION PROTEINS

Andrs Joaqun Lpez-Contreras, the first author of the study, adds: "Some of these proteins were already known but this study has also allowed us to identify new proteins needed for DNA replication, opening up new research paths in the field."

DNA replication in cancer cells occurs in an uncontrolled or aberrant manner, which makes it the Achilles' heel of oncology research. According to Fernndez-Capetillo, the next step consists of applying these new technologies to finding differences in the replication machinery of normal and cancer cells, so that new therapeutic strategies can be found to treat cancer.

"If we manage to find fundamental differences between replication in normal cells and in cancer cells, we will surely be able to find new therapeutic targets on which to focus future treatments in the fight against cancer," says the CNIO researcher.


'/>"/>

Contact: Nuria Noriega
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Related biology news :

1. Researchers abuzz over caffeine as cancer-cell killer
2. An important discovery in breast cancer by IRCM researchers
3. UCLA researchers find nanodiamonds could improve effectiveness of breast cancer treatment
4. Clues to heart disease in unexpected places, Temple researchers discover
5. BUSM researchers identify novel approach to study COPD and treatment efficacy
6. Researchers call for marine observation network
7. Biofilms help Salmonella survive hostile conditions, Virginia Tech researchers say
8. U-M researchers find new way to clear cholesterol from the blood
9. Dartmouth researchers find there is no single sexy chin
10. Researchers design drug to restore cell suicide in HPV-related head and neck cancer
11. Researchers shine light on how stress circuits learn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Alex,s Lemonade ... announced that that it will open a state-of-the-art bioinformatics ... childhood cancer research. This announcement comes as Liz ... attends the National Cancer Moonshot Summit in ... Dr. Biden as a participant and advocate of pediatric ...
(Date:6/27/2016)... , June 27, 2016  Global demand ... 4.6 percent through 2020 to $7.2 billion.  This ... and beverages, cleaning products, biofuel production, animal feed, ... biotechnology, diagnostics, and biocatalysts). Food and beverages will ... driven by increasing consumption of products containing enzymes ...
(Date:6/27/2016)... , June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ... advised by its major shareholders, Clean Technology Fund I, ... United States based venture capital funds which ... Biorem (on a fully diluted, as converted basis), that ... of their entire equity holdings in Biorem to TUS ...
(Date:6/27/2016)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life ... development of innovative products and services, announced today that ... denied its petition to review decisions by ... Patent No. 6,258,540 (",540 Patent") are not patent eligible ... Court,s Mayo Collaborative Services v. Prometheus Laboratories decision.  In ...
Breaking Biology Technology: